The Uromigos Episode 374: Mechanisms of HIF Resistance | GU Oncology Now
Dr. Jim Brugarolas joins the podcast to discuss his talk from IKCS 2024 and the broad topic of resistance to HIF inhibitors.
Related Articles
Palliative Care Early After Cancer Diagnosis Impacts Outcomes at End of Life | Cancer Nursing Today
This study is important for oncology nurses because we know that not all cancer centers can provide specialized palliative care like at this cancer center.
FDA Issues Complete Response Letter for Subcutaneous Amivantamab in NSCLC | Docwire News
The Complete Response Letter “is related to observations as part of a standard pre-approval inspection at a manufacturing facility,” according to Johnson & Johnson officials.
There are more heart attacks on Christmas than any other day of the year
We sing about how Christmas brings “tidings of comfort and joy,” but the holiday also brings something not so “merry and bright.”
Light and moderate wine consumption linked to lower risk of cardiovascular complications
Light and moderate consumption of wine is associated with a lower risk of cardiovascular complications, according to a multicenter study led by researchers from the…
Improved Cardiovascular Health Reduces Mortality Among Patients With Arthritis
Maintaining ideal cardiovascular health may lower the risk for all-cause mortality among patients with arthritis.
2025 International Clinical Research Course (ICRC) Italy Application – Application Portal
ASCO and AIOM are pleased to present the International Clinical Research Course (ICRC) in Rome, Italy, March 14-15, 2025. This interactive course is for beginning…
Gilead Sciences : Submits New Drug Application to U.S. Food and Drug Administration for Twice-Yearly Lenacapavir for HIV Prevention
Lenacapavir Named 2024 Breakthrough of the Year by Science Magazine Foster City, Calif., December 19, 2024 – Gilead Sciences, Inc. today announced the company completed…
Implementing the Rural Appalachian Lung Cancer Screening Initiative: Dr. Gieske Shares Insights | Docwire News
Michael R. Gieske, MD, of the St. Elizabeth Cancer Center, discusses the Rural Appalachian Lung Cancer Screening Initiative at IASLC 2024 World Conference on Lung…
Dr. Yao discusses ASH 2024 study on non-CLL-type MBL
Recorded at the 66th American Society of Hematology Annual Meeting and Exposition, Yuan Yao, MD, MS, discusses the ASH abstract (No.397) titled,
Emerging Therapies and Hope: Diffuse Large B-cell Lymphoma – The Bloodline with LLS
Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin Karimi from the University of…
